1. Home
  2. HALO vs AGI Comparison

HALO vs AGI Comparison

Compare HALO & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • AGI
  • Stock Information
  • Founded
  • HALO 1998
  • AGI 2003
  • Country
  • HALO United States
  • AGI Canada
  • Employees
  • HALO N/A
  • AGI N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • AGI Precious Metals
  • Sector
  • HALO Health Care
  • AGI Basic Materials
  • Exchange
  • HALO Nasdaq
  • AGI Nasdaq
  • Market Cap
  • HALO 7.4B
  • AGI 10.8B
  • IPO Year
  • HALO N/A
  • AGI 1999
  • Fundamental
  • Price
  • HALO $50.13
  • AGI $24.60
  • Analyst Decision
  • HALO Buy
  • AGI Buy
  • Analyst Count
  • HALO 9
  • AGI 4
  • Target Price
  • HALO $63.78
  • AGI $30.38
  • AVG Volume (30 Days)
  • HALO 2.1M
  • AGI 4.3M
  • Earning Date
  • HALO 05-06-2025
  • AGI 04-30-2025
  • Dividend Yield
  • HALO N/A
  • AGI 0.40%
  • EPS Growth
  • HALO 55.40
  • AGI 19.70
  • EPS
  • HALO 3.76
  • AGI 0.62
  • Revenue
  • HALO $1,084,306,000.00
  • AGI $1,402,300,000.00
  • Revenue This Year
  • HALO $20.06
  • AGI $26.44
  • Revenue Next Year
  • HALO $24.20
  • AGI $10.10
  • P/E Ratio
  • HALO $17.71
  • AGI $40.43
  • Revenue Growth
  • HALO 25.64
  • AGI 33.63
  • 52 Week Low
  • HALO $41.28
  • AGI $15.01
  • 52 Week High
  • HALO $70.51
  • AGI $31.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 36.86
  • AGI 41.51
  • Support Level
  • HALO $58.38
  • AGI $26.41
  • Resistance Level
  • HALO $69.94
  • AGI $27.15
  • Average True Range (ATR)
  • HALO 3.06
  • AGI 0.93
  • MACD
  • HALO -0.11
  • AGI -0.33
  • Stochastic Oscillator
  • HALO 6.60
  • AGI 27.49

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AGI Alamos Gold Inc.

Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.

Share on Social Networks: